世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

米国血液透析・腹膜透析市場規模・シェア・動向分析レポート タイプ別(血液透析、腹膜透析)、製品別(デバイス、消耗品、サービス)、エンドユース別、セグメント別予測、2023~2030年


U.S. Hemodialysis And Peritoneal Dialysis Market Size, Share & Trends Analysis Report By Type (Hemodialysis, Peritoneal Dialysis), By Product (Devices, Consumables, Service), By End-use, And Segment Forecasts, 2023 - 2030

米国血液透析・腹膜透析市場の成長・トレンド Grand View Research, Inc.の新しいレポートによると、米国の血液透析および腹膜透析市場は、2030年までに579億3000万米ドルに達すると予測されています。2023年... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年1月5日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
141 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

米国血液透析・腹膜透析市場の成長・トレンド

Grand View Research, Inc.の新しいレポートによると、米国の血液透析および腹膜透析市場は、2030年までに579億3000万米ドルに達すると予測されています。2023年から2030年までのCAGRは6.10%で拡大すると予想されています。高齢者人口の顕著な増加とともに、腎疾患の発生率が増加していることが、米国における血液透析と腹膜透析の市場需要を促進しています。さらに、新製品開発のための資金調達が増加していることが、この市場に有利なシナリオを提供します。

近年、COVID-19の大流行により、国内では入院患者数が急増し、感染症のホットスポットと化しています。このパンデミックは、慢性腎臓病(CKD)、糖尿病、高血圧などの併存疾患の有病率の高さから、国内における腎代替療法(RRT)の需要増につながりました。この間、透析装置の需要は大幅に増加しました。American Society of Nephrologyに掲載された調査研究によると、AKIの症例を管理するために必要な透析装置の需要は、2020年春にニューヨークでベースラインより279%増幅しました。

さらに、末期腎不全(ESRD)の有病率が上昇していることも、市場を促進すると思われます。例えば、USRDSによると、2020年にはESRDに罹患する人が2.5%増加した。また、2010年から2019年にかけて、ESRDに苦しむ人々の14.84%の増加を占めるESRDの治療を受けた合計130,400人の患者が新たに登録された。

米国血液透析・腹膜透析市場レポートハイライト

- タイプ別では、血液透析分野が2022年に88.70%のシェアを獲得し、金額ベースで市場を支配しており、予測期間中の年平均成長率は6.19%と最も高くなると予想されます。ESRD患者数の増加、腎臓病を患う高齢者人口の急増が、このセグメントの成長を促進する大きな要因となっています。

- 製品別では、2022年にサービス分野が68.00%のシェアで市場を支配しました。先進国での最新技術の普及率の高さと相まって、透析サービスを提供するプロバイダーの数が増加していることが、このセグメントの成長に寄与しています。

- エンドユーススコープでは、病院ベースのセグメントが2022年に79.39%のシェアを占め、市場を支配した。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Type
1.1.2 Product
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Prevalence Of Acute Kidney Injury (Aki) And Associated Chronic Kidney Diseases
3.5.1.2 Increasing Incidence And Prevalence Of Esrd
3.5.1.3 Introduction To Technologically Advanced Products
3.5.1.4 Growing Geriatric Population
3.5.1.5 Increase In Number Of Diabetes Patient
3.5.2 Market Restraints Analysis
3.5.2.1 Risk And Complications Associated With Dialysis
3.5.2.2 Issues With Product Approval & Commercialization
3.5.3 Market Opportunities Analysis
3.5.3.1 Increased Demand For Home Care Dialysis Services
3.5.3.2 Growing Government Initiatives And Recommendations For Efficient Kidney Disease Management
3.6 Hemodialysis And Peritoneal Dialysis: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact Of Covid-19 On Market & Post Pandemic Recovery Analysis
Chapter 4 U.S. Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By Type, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
4.5.1 Hemodialysis
4.5.1.1 Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.1.2 Conventional
4.5.1.2.1 Conventional Market, 2018 - 2030 (USD Million)
4.5.1.3 Short Daily Hemodialysis
4.5.1.3.1 Short Daily Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.1.4 Nocturnal Hemodialysis
4.5.1.4.1 Nocturnal Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.2 Peritoneal Dialysis
4.5.2.1 Peritoneal Dialysis Market, 2018 - 2030 (USD Million)
4.5.2.2 Continuous Ambulatory Peritoneal Dialysis (Capd)
4.5.2.2.1 continuous Ambulatory Peritoneal Dialysis (Capd) Market, 2018 - 2030 (USD Million)
4.5.2.3 Nocturnal Hemodialysis
4.5.2.3.1 Nocturnal Hemodialysis Market, 2018 - 2030 (USD Million)
Chapter 5 Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
5.1 Definition And Scope
5.2 Product Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By Product, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
5.5.1 Device
5.5.1.1 Device Market, 2018 - 2030 (USD Million)
5.5.1.2 Machine
5.5.1.2.1 Machine Market, 2018 - 2030 (USD Million)
5.5.1.3 Water Treatment System
5.5.1.3.1 Water Treatment System Market, 2018 - 2030 (USD Million)
5.5.1.4 Dialyzers
5.5.1.4.1 Dialyzers Market, 2018 - 2030 (USD Million)
5.5.1.5 Others
5.5.1.5.1 Others Market, 2018 - 2030 (USD Million)
5.5.2 Consumables
5.5.2.1 Consumables Market, 2018 - 2030 (USD Million)
5.5.2.2 Bloodlines
5.5.2.2.1 Bloodlines Market, 2018 - 2030 (USD Million)
5.5.2.3 Concentrates
5.5.2.3.1 Concentrates Market, 2018 - 2030 (USD Million)
5.5.2.4 Catheters
5.5.2.4.1 Catheters Market, 2018 - 2030 (USD Million)
5.5.2.5 Others
5.5.2.5.1 Others Market, 2018 - 2030 (USD Million)
5.5.3 Service
5.5.3.1 Service Market, 2018 - 2030 (USD Million)
Chapter 6 U.S. Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
6.1 Definition And Scope
6.2 End-Use Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By End-Use, 2018 To 2030
6.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
6.5.1 Home-Based
6.5.1.1 Home-Based Market, 2018 - 2030 (USD Million)
6.5.2 Hospital-Based
6.5.2.1 Hospital-Based Market, 2018 - 2030 (USD Million)
Chapter 7 U.S. Hemodialysis And Peritoneal Dialysis Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Company Profiles
7.3.1 Fresenius Medical Care Ag & Co. Kgaa
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Baxter International
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 B. Braun Avitum Ag
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Nipro Corporation
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Medtronic
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Nikkiso Co., Ltd.
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Asahi Kasei Corporation
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Cantel Medical Corporation
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.9 DaVita Inc.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Becton, Dickinson and Company
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives

 

ページTOPに戻る


 

Summary

U.S. Hemodialysis And Peritoneal Dialysis Market Growth & Trends

The U.S. hemodialysis and peritoneal dialysis market is anticipated to reach USD 57.93 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.10% from 2023 to 2030. The increasing incidence of renal diseases, alongside the noteworthy growth in the geriatric population, has fueled the market demand for hemodialysis and peritoneal dialysis in the U.S. Moreover, growing funding for the development of new products will provide a lucrative scenario for the market.

Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization and infection hotspots around the country. The pandemic led to a growth in demand for Renal Replacement Therapy (RRT) in the country, owing to the higher prevalence of comorbid conditions, such as Chronic Kidney Diseases (CKD), diabetes, and hypertension. The demand for dialysis machines surged significantly during this period. As per a research study published in the American Society of Nephrology, the demand for dialysis machines required to manage cases of AKI amplified by 279% over baseline during the spring of 2020 in New York City.

Moreover, the rising prevalence of End-stage Renal Disease (ESRD) is likely to propel the market. For instance, according to USRDS, in 2020, there was an increase of 2.5% in people suffering from ESRD. A total of 130,400 new patients were registered who were treated for ESRD which accounted increase of 14.84% of people suffering from ESRD from 2010-2019.

U.S. Hemodialysis And Peritoneal Dialysis Market Report Highlights

• Based on type, hemodialysis segment dominated the market in terms of value with a share of 88.70% in 2022 and is expected to grow at the highest CAGR of 6.19% during the forecast period. The rising number of ESRD patients, surge in geriatric population suffering from kidney diseases, are significant factors driving the segment growth.

• Based on product, service segment dominated the market in 2022 with a share of 68.00%. The growing number of providers offering dialysis services coupled with the higher penetration of the latest technology in developed countries is contributing to the segment growth.

• In end-use scope, hospital-based segment dominated the market with a share of 79.39% in 2022, owing to the increased focus of players in establishing independent dialysis centers, and the growing preference of patients to opt for treatment in in-center dialysis



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Type
1.1.2 Product
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Hemodialysis And Peritoneal Dialysis Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Prevalence Of Acute Kidney Injury (Aki) And Associated Chronic Kidney Diseases
3.5.1.2 Increasing Incidence And Prevalence Of Esrd
3.5.1.3 Introduction To Technologically Advanced Products
3.5.1.4 Growing Geriatric Population
3.5.1.5 Increase In Number Of Diabetes Patient
3.5.2 Market Restraints Analysis
3.5.2.1 Risk And Complications Associated With Dialysis
3.5.2.2 Issues With Product Approval & Commercialization
3.5.3 Market Opportunities Analysis
3.5.3.1 Increased Demand For Home Care Dialysis Services
3.5.3.2 Growing Government Initiatives And Recommendations For Efficient Kidney Disease Management
3.6 Hemodialysis And Peritoneal Dialysis: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact Of Covid-19 On Market & Post Pandemic Recovery Analysis
Chapter 4 U.S. Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By Type, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
4.5.1 Hemodialysis
4.5.1.1 Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.1.2 Conventional
4.5.1.2.1 Conventional Market, 2018 - 2030 (USD Million)
4.5.1.3 Short Daily Hemodialysis
4.5.1.3.1 Short Daily Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.1.4 Nocturnal Hemodialysis
4.5.1.4.1 Nocturnal Hemodialysis Market, 2018 - 2030 (USD Million)
4.5.2 Peritoneal Dialysis
4.5.2.1 Peritoneal Dialysis Market, 2018 - 2030 (USD Million)
4.5.2.2 Continuous Ambulatory Peritoneal Dialysis (Capd)
4.5.2.2.1 continuous Ambulatory Peritoneal Dialysis (Capd) Market, 2018 - 2030 (USD Million)
4.5.2.3 Nocturnal Hemodialysis
4.5.2.3.1 Nocturnal Hemodialysis Market, 2018 - 2030 (USD Million)
Chapter 5 Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
5.1 Definition And Scope
5.2 Product Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By Product, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
5.5.1 Device
5.5.1.1 Device Market, 2018 - 2030 (USD Million)
5.5.1.2 Machine
5.5.1.2.1 Machine Market, 2018 - 2030 (USD Million)
5.5.1.3 Water Treatment System
5.5.1.3.1 Water Treatment System Market, 2018 - 2030 (USD Million)
5.5.1.4 Dialyzers
5.5.1.4.1 Dialyzers Market, 2018 - 2030 (USD Million)
5.5.1.5 Others
5.5.1.5.1 Others Market, 2018 - 2030 (USD Million)
5.5.2 Consumables
5.5.2.1 Consumables Market, 2018 - 2030 (USD Million)
5.5.2.2 Bloodlines
5.5.2.2.1 Bloodlines Market, 2018 - 2030 (USD Million)
5.5.2.3 Concentrates
5.5.2.3.1 Concentrates Market, 2018 - 2030 (USD Million)
5.5.2.4 Catheters
5.5.2.4.1 Catheters Market, 2018 - 2030 (USD Million)
5.5.2.5 Others
5.5.2.5.1 Others Market, 2018 - 2030 (USD Million)
5.5.3 Service
5.5.3.1 Service Market, 2018 - 2030 (USD Million)
Chapter 6 U.S. Hemodialysis And Peritoneal Dialysis Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
6.1 Definition And Scope
6.2 End-Use Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 U.S. Hemodialysis And Peritoneal Dialysis Market, By End-Use, 2018 To 2030
6.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
6.5.1 Home-Based
6.5.1.1 Home-Based Market, 2018 - 2030 (USD Million)
6.5.2 Hospital-Based
6.5.2.1 Hospital-Based Market, 2018 - 2030 (USD Million)
Chapter 7 U.S. Hemodialysis And Peritoneal Dialysis Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Company Profiles
7.3.1 Fresenius Medical Care Ag & Co. Kgaa
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Baxter International
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 B. Braun Avitum Ag
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Nipro Corporation
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Medtronic
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Nikkiso Co., Ltd.
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Asahi Kasei Corporation
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Cantel Medical Corporation
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.9 DaVita Inc.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Becton, Dickinson and Company
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る